HUDDINGE, Sweden--(BUSINESS WIRE)--Regulatory News:
Medivir AB (STO:MVIR-B):
Financial summary for the third quarter*
July to September 2014 (2013)
· Net turnover totalled SEK 617.8 million (SEK 80.2 m), SEK 516.4 million (SEK 0 m) of which comprised royalties for simeprevir.
Help employers find you! Check out all the jobs and post your resume.
Medivir AB (STO:MVIR-B):
Financial summary for the third quarter*
July to September 2014 (2013)
· Net turnover totalled SEK 617.8 million (SEK 80.2 m), SEK 516.4 million (SEK 0 m) of which comprised royalties for simeprevir.
Help employers find you! Check out all the jobs and post your resume.
